Screening for Atrial Fibrillation: Risks, Benefits, and Implications On Future Clinical Practice
Open Access
- 25 June 2024
- journal article
- review article
- Published by Springer Nature in Current Treatment Options in Cardiovascular Medicine
- Vol. 26 (8) , 233-242
Abstract
Purpose of the Review: Atrial fibrillation (AF) is the most commonly encountered arrhythmia in clinical practice with constantly rising prevalence due to an overall increased ageing population with multiple co-morbidities. Since AF predisposes patients to debilitating and life-threatening complications such as stroke and coronary artery disease (CAD), much emphasis has been placed recently on early recognition and management of the disease to prevent complications. Hence, the focus of this review is deliberate on the potential risks and benefits of screening initiatives for AF and their ultimate impact on healthcare systems the associated disease burden. Recent Findings: Due to lack of clarity on the matter, implementation of national screening programmes for AF are not currently recommended by health authorities in the UK and USA. Nevertheless, recent multicentre studies such as AF-SCREEN and STROKESTOP have concluded that select groups may benefit from screening for this disease. Research in the use of electrocardiographs (ECGs) and wearable smart devices for early detection of AF has also demonstrated a marked decrease in AF-associated thromboembolic events Summary: Although there is a dire need for further robust clinical trials to investigate various screening modalities and develop a robust criterion for AF screening, current literature supports the implementation of a national screening programme to combat the rate of AF-associated complications which continue to challenge the healthcare system.Keywords
All Related Versions
This publication has 71 references indexed in Scilit:
- Generalizability of the CASTLE-AF trial: Catheter ablation for patients with atrial fibrillation and heart failure in routine practiceHeart Rhythm, 2020
- Accurate detection of atrial fibrillation from 12-lead ECG using deep neural networkComputers in Biology and Medicine, 2020
- Screening for Atrial Fibrillation Using Economical and Accurate Technology (From the SAFETY Study)The American Journal of Cardiology, 2018
- Competence of general practitioners in requesting and interpreting ECGs - a case vignette studyNetherlands Heart Journal, 2018
- Safety of Intravenous Diltiazem in Reduced Ejection Fraction Heart Failure with Rapid Atrial FibrillationClinical Drug Investigation, 2018
- A comparison of the CHARGE–AF and the CHA2DS2-VASc risk scores for prediction of atrial fibrillation in the Framingham Heart StudyAmerican Heart Journal, 2016
- Validity of the Polar V800 heart rate monitor to measure RR intervals at restEuropean Journal of Applied Physiology, 2015
- WatchBP Home A for Opportunistically Detecting Atrial Fibrillation During Diagnosis and Monitoring of Hypertension: A NICE Medical Technology GuidanceApplied Health Economics and Health Policy, 2014
- Transesophageal Echocardiography in Atrial FibrillationCardiac Electrophysiology Clinics, 2014
- Vascular Holism: The Epidemiology of Vascular DiseaseAnnals of Vascular Surgery, 1995